Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Pinder

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Nature|October 24, 1970
Possible dopamine derivatives capable of crossing the blood-brain barrier in relation to ParkinsonismR M Pinder
The Journal of Clinical Psychiatry|July 11, 2001
Depression: the relevance of the time factorR M Pinder
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1985
Adrenoreceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect?R M Pinder
The Journal of Clinical Psychiatry|December 31, 1997
The pharmacologic rationale for the clinical use of antidepressantsR M Pinder
L'Encephale|January 1, 1981
[Predicted pharmacology of an antidepressant]R M Pinder
Progress in Medicinal Chemistry|January 1, 1971
Recent advances in the chemotherapy of malariaR M Pinder
Nederlands Tijdschrift Voor Geneeskunde|March 16, 1991
[The overdose risk in prescribing of antidepressive agents]R M Pinder
Progress in Medicinal Chemistry|January 1, 1972
The pharmacotherapy of ParkinsonismR M Pinder
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1997
Designing a new generation of antidepressant drugsR M Pinder
Journal of Psychopharmacology (Oxford, England)|December 8, 2004
Alcohol, wine and mental health: focus on dementia and strokeR M Pinder, M Sandler
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Nature|October 24, 1970
Possible dopamine derivatives capable of crossing the blood-brain barrier in relation to ParkinsonismR M Pinder
The Journal of Clinical Psychiatry|July 11, 2001
Depression: the relevance of the time factorR M Pinder
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1985
Adrenoreceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect?R M Pinder
The Journal of Clinical Psychiatry|December 31, 1997
The pharmacologic rationale for the clinical use of antidepressantsR M Pinder
L'Encephale|January 1, 1981
[Predicted pharmacology of an antidepressant]R M Pinder
Progress in Medicinal Chemistry|January 1, 1971
Recent advances in the chemotherapy of malariaR M Pinder
Nederlands Tijdschrift Voor Geneeskunde|March 16, 1991
[The overdose risk in prescribing of antidepressive agents]R M Pinder
Progress in Medicinal Chemistry|January 1, 1972
The pharmacotherapy of ParkinsonismR M Pinder
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1997
Designing a new generation of antidepressant drugsR M Pinder
Journal of Psychopharmacology (Oxford, England)|December 8, 2004
Alcohol, wine and mental health: focus on dementia and strokeR M Pinder, M Sandler
Pageof 8